Hemanext Inc. has secured new venture-capital funding ahead of plans to seek U.S. regulatory authorization for a medical device designed to improve blood storage and help patients who depend heavily on donated blood.
Lexington, Mass.-based Hemanext has collected $15 million in new funding and has now raised a total of more than $100 million.
Donated…
IoT Analytics launched the This autumn/2024 outcomes of their quarterly firm earnings name evaluation. This evaluation is predicated on a…
Former Valkyrie CIO and co-founder Steven McClurg unpacks the influence of the…
“Winter squash” is a little bit of a misnomer. In fact, these…
The global economy could suffer a modest blow from the…
